Parsifal Capital Management LP Buys Shares of 36,200 UnitedHealth Group Incorporated (NYSE:UNH)

Parsifal Capital Management LP purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 36,200 shares of the healthcare conglomerate’s stock, valued at approximately $21,165,000. UnitedHealth Group makes up 1.4% of Parsifal Capital Management LP’s investment portfolio, making the stock its 15th largest holding.

A number of other large investors have also made changes to their positions in UNH. Delta Financial Group Inc. grew its position in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the period. Signature Resources Capital Management LLC grew its position in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the period. Saxony Capital Management LLC boosted its position in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after buying an additional 18 shares during the period. GoalVest Advisory LLC boosted its position in shares of UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after buying an additional 18 shares during the period. Finally, Fiduciary Group LLC boosted its position in shares of UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on UNH shares. Stephens lowered their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Barclays raised their price target on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday, November 27th. Finally, UBS Group cut their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $621.58.

UnitedHealth Group Trading Down 0.5 %

Shares of UnitedHealth Group stock opened at $605.23 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market capitalization of $556.98 billion, a P/E ratio of 39.43, a P/E/G ratio of 1.79 and a beta of 0.58. The business has a 50 day moving average price of $586.72 and a 200 day moving average price of $557.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.39%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.